The global bio-implants market is projected to grow at a CAGR of 7.2% during the forecast period. Increasing prevalence of chronic disorders, rapidly growing geriatric population, along with rapid technologically advancements are factors driving the bio-implants market.

Adroit Market Research report on global bio-implants market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 and 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market based on Porter's five forces analysis and positions the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global bio-implants market have been studied in detail.

Bio-implants are bioengineered products that are used in tissues or human living cells with the use of active agents or synthetic constructions to replicate particular physiological activities or treat the disease's etiology. Increase in preference for minimally invasive treatments, as well as growing awareness of bio-implants will positively boost industry over the next few years. Increase in geriatric patient pool susceptible to chronic disorders will further fuel the growth of the market in the future. For instance, majority of the geriatric patient pool require dental implants for restorative care which fuels the demand for bio-implants.

The global bio-implants market has been segmented based on type, material, origin, and region. Based on type, the global bio-implants market is categorized into cardiovascular implants, dental implants, spinal implants, orthopedic implants, and ophthalmic implants. Orthopedic implants segment held substantial share of the market in 2020. Increase in prevalence of orthopedic disorders among surging elderly patient pool will drive the demand for orthopedic implants in the next few years. On the basis of material, the global bio-implants market is segmented into ceramics, biomaterials metals, alloys, and polymers. Polymers segment is anticipated to grow at a healthy rate over the coming few years. In regeneration medicine and tissue engineering, natural and synthetic polymers are commonly employed as scaffolds or bio-implants. Polymer coatings also promote the biocompatibility and bio-functionality of bio-implants. Origin-wise, the global bio-implants market is segregated into allograft, xenograft, autograft and synthetic. Xenograft accounted for majority of the market share in 2020.

North America dominated the global bio-implants market in 2020. Rapidly growing geriatric population, high prevalence of dental diseases such as malocclusion, and periodontal diseases in the U.S. and Canada are major factors driving the growth for bio-implants in the region. According to the American College of Prosthodontists (ACP), around 23 million geriatric people in the U.S. are completely edentulous and another 12 million are edentulous in one arch. However, Asia Pacific bio-implants market is anticipated to grow at a rapid pace over the forecast period. Presence of large geriatric population, increase in disposable income, and high prevalence of chronic disorders will propel the global bio-implants in the region in the next few years.

Major players operating in the global bio-implants market include Medtronic, Arthrex, Inc., Zimmer Biomet, Cochlear, Ltd., St. Jude Medical, Orthofix Holdings, Inc., Straumann AG, Stryker Corporation, Smith & Nephew and DePuy Synthes among others.

Key Segments of the Global Bio-implants Market

Type Overview, 2018-2028 (USD Million)

• Cardiovascular Implants
• Dental Implants
• Spinal Implants
• Orthopedic Implants
• Ophthalmic Implants

Material Overview, 2018-2028 (USD Million)

• Ceramics
• Polymers
• Biomaterials Metals
• Alloys

Origin Overview, 2018-2028 (USD Million)

• Autograft
• Allograft
• Xenograft
• Synthetic

Regional Overview, 2018-2028 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • United Kingdom
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle  East & Africa